ABVC BioPharma, Inc. Reports Q3 2024 Financial Results and Operational Milestones
November 14, 2024 09:00 ET
|
ABVC BioPharma, Inc.
ABVC BioPharma Achieved its First Operational Profit, with a 102% Improvement over the Third Quarter of Last Year.Incremental Payments Received based on Executed Global Licensing Agreements that could...
SINTX Technologies Provides Positive Strategic Business Update for Q3 2024
November 14, 2024 06:00 ET
|
SINTX Technologies, Inc.
Salt Lake City, UT, Nov. 14, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics company that develops and commercializes materials,...
Cyclacel Pharmaceuticals Reports Third Quarter Financial Results and Provides Business Update
November 12, 2024 16:45 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative...
Titanium Transportation Group Reports Steady Q3 2024 Performance with 24% Increase in Volume in Logistics Segment
November 11, 2024 17:45 ET
|
Titanium Transportation Group Inc
Consolidated third quarter revenue grew by 5.1% compared to the previous year, driven by strong performance in the Logistics segmentLogistics segment delivered volume growth of 24%, resulting in 18%...
Kneat Achieves Record Results in Growth and Profitability
November 06, 2024 17:04 ET
|
kneat.com, inc.
Kneat achieves record results in growth and profitability, as third-quarter 2024 revenue and gross profit growth accelerate to 52% and 78% respectively,
VICAT CHIFFRE D'AFFAIRES T3 2024
November 04, 2024 12:00 ET
|
VICAT
Croissance organique du chiffre d’affaires de +3,3% sur 9 moisUn 3ème trimestre impacté par un effet de change négatif, notamment en Méditerranée, et une base de comparaison élevéeConfirmation des...
Vicat Q3 2024 Sales
November 04, 2024 12:00 ET
|
VICAT
Organic sales growth of +3.3% over the first nine monthsThird quarter impacted by negative currency effects, especially in the Mediterranean region, and a high base of comparison2024 EBITDA targets...
BioNTech veröffentlicht Ergebnisse für das dritte Quartal 2024 sowie Informationen zur Geschäftsentwicklung
November 04, 2024 06:45 ET
|
BioNTech SE
Veröffentlichung klinischer Daten für mehrere Produktkandidaten aus verschiedenen Wirkstoffklassen, einschließlich des bispezifischen Antikörperkandidaten BNT327/PM8002 und des...
BioNTech Announces Third Quarter 2024 Financial Results and Corporate Update
November 04, 2024 06:45 ET
|
BioNTech SE
Presented clinical data for multiple assets across modalities, including bispecific antibody candidate BNT327/PM8002 and mRNA cancer vaccine candidate BNT113 based on BioNTech’s FixVac platform...
Black Diamond Reports Third Quarter 2024 Results and Increases Dividend by 17%
October 31, 2024 18:57 ET
|
Black Diamond Group Limited
CALGARY, Alberta, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Black Diamond Group Limited ("Black Diamond", the "Company" or "we"), (TSX:BDI), a leading provider of space rental and workforce accommodation...